Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases.
Priyakshi Kalita-de CroftMalcolm LimHaarika ChittooryXavier M de LucaJamie R KutasovicBryan W DayFares Al-EjehPeter T SimpsonAmy E McCart ReedSunil R LakhaniJodi M SaunusPublished in: Therapeutic advances in medical oncology (2020)
Preclinical studies investigating HER4 and nuclear YAP combination therapy strategies are warranted.